2029 Disease Pharma Companies Vaccine 
Drug Discovery World
OCTOBER 4, 2022
This year’s event will cover some of the most exciting advancements in areas spanning screening, automation, high content imaging, disease models, cell and gene therapies and how innovation is being driven through partnerships and collaborations. This year has seen some major deals announced by big pharma companies.
Vial
MARCH 1, 2024
billion by 2029. Existing lab services include bioanalytical, biomarker , and vaccine sciences labs in Virginia; a GMP lab in Ireland; central labs and biomarker operations in Belgium, Kentucky, and Singapore; and bioanalytical, biomarker, vaccine sciences, and central labs in China. from 2024 to reach US$129.8
Expert insights. Personalized for you.
130 
Let's personalize your content